Research challenges periprocedural MI biomarker threshold

03/6/2012 | (Montreal) (free registration)

Researchers from the Harvard Clinical Research Institute say the current troponin cutoff to determine periprocedural MI is too sensitive and should be adjusted. "The major finding from our paper is when CK-MB and troponin are both used to diagnose periprocedural MI, they diagnose very different events if they are taken at the same threshold of three times the [upper limit of normal] ULN, which is the current task force definition," senior author Dr. Donald E. Cutlip said.

View Full Article in: (Montreal) (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
Boise, ID